Miti Biosystems

Miti Biosystems is a biotechnology company specialized in the production of polycyclic peptide libraries for the discovery of peptide drugs and mimotopes. Using our patented platform technology, we apply randomization techniques on natural product scaffolds to realize their chemical space.

Using natural product scaffolds, we are able to harness the bio-combinatorial potential of nature, as these scaffolds have been selected and optimized during millions of years of evolution. The randomization procedure leads to several billion chemically diverse structures that are displayed on bacteriophage M13, thus enabling fast screening for substances with desired phasic-chemical properties.